From new KRAS and HER2 inhibitors to home-administered immunotherapy, recent trials mark a turning point in how metastatic lung cancer is managed.

Immune checkpoint inhibitors, a class of immunotherapies that help immune cells attack cancer more effectively, have revolutionized cancer treatment. However, fewer than 20% of patients respond to ...

Researchers from Touro University and Lovelace Biomedical are Developing an Innovative Treatment for Lung Cancer ...

Dame Esther Rantzen has said it would be “lovely” to meet her late husband Desmond Wilcox again in heaven, as she confirmed that her life-extending wonder drug has stopped working. The That’s Life ...

The following is a summary of “Mediating effects of coping strategies between symptom clusters and quality of life in lung ...

Pulmonary sarcoidosis is a lung disease characterized by granulomas—tiny clumps of immune cells that form in response to ...

A gene once believed to be extremely rare may actually be surprisingly common—and capable of quietly raising the risk of ...

Maida Mangiameli finally gave up smoking when her granddaughter was born. That's when her troubles really started.

Early detection is the key to surviving lung cancer, but Oklahomans rank 44th out of 47 states in early-stage diagnosis ...

The EU approved AstraZeneca's Enhertu for certain breast cancer patients and Imfinzi for resectable NSCLC, showing ...

At 38, William Lindley was a father of three kids and passionate about his job in law enforcement. But, after months of ...

Scientists are looking for answers about how these confounding trips, known as metastases, occur throughout the human body ...